Isofol Medical AB (publ) publishes interim report, January–September 2025
GOTHENBURG, Sweden, November 12, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), (”Isofol” or the ”Company”), announced today that […]
GOTHENBURG, Sweden, November 12, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), (”Isofol” or the ”Company”), announced today that […]
GOTHENBURG, Sweden, November 4, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), (”Isofol” or the ”Company”), announced today that
GOTHENBURG, Sweden, October 28, 2025 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) hereby invites investors and shareholders to an
GOTHENBURG, Sweden, October 16, 2025 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) announces today that the company will participate
GOTHENBURG, Sweden, September 30, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that the company has successfully
GOTHENBURG, Sweden, September 26, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that the transfer of the
GOTHENBURG, Sweden, August 26, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announced today that the company’s interim report
GOTHENBURG, Sweden, August 21, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), hereby invites investors, analysts and media to
GOTHENBURG, Sweden, July 31, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces new number of shares and votes
GOTHENBURG, Sweden, July 16, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that the company has successfully